Blockade of sarcolemmal TRPV2 accumulation inhibits progression of dilated cardiomyopathy
Tóm tắt
Từ khóa
Tài liệu tham khảo
Hughes, 2005, New insights into the pathology of inherited cardiomyopathy, Heart, 91, 257, 10.1136/hrt.2004.040337
Fatkin, 2002, Molecular mechanisms of inherited cardiomyopathies, Physiol Rev, 82, 945, 10.1152/physrev.00012.2002
Seidman, 2001, The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms, Cell, 104, 557, 10.1016/S0092-8674(01)00242-2
Campbell, 1989, Association of dystrophin and an integral membrane glycoprotein, Nature, 338, 259, 10.1038/338259a0
Nigro, 1997, Identification of the Syrian hamster cardiomyopathy gene, Hum Mol Genet, 6, 601, 10.1093/hmg/6.4.601
Jeong, 2012, Metabolic stress, reactive oxygen species, and arrhythmia, J Mol Cell Cardiol, 52, 454, 10.1016/j.yjmcc.2011.09.018
Toko, 2010, Ca2+/calmodulin-dependent kinase IIdelta causes heart failure by accumulation of p53 in dilated cardiomyopathy, Circulation, 122, 891, 10.1161/CIRCULATIONAHA.109.935296
Beuckelmann, 1992, Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure, Circulation, 85, 1046, 10.1161/01.CIR.85.3.1046
Lindner, 2002, Calcium sparks in human ventricular cardiomyocytes from patients with terminal heart failure, Cell Calcium, 31, 175, 10.1054/ceca.2002.0272
Louch, 2004, Reduced synchrony of Ca2+ release with loss of T-tubules-a comparison to Ca2+ release in human failing cardiomyocytes, Cardiovascular Research, 62, 63, 10.1016/j.cardiores.2003.12.031
Eder, 2011, TRPC channels as effectors of cardiac hypertrophy, Circ Res, 108, 265, 10.1161/CIRCRESAHA.110.225888
Nilius, 2007, Transient receptor potential cation channels in disease, Physiol Rev, 87, 165, 10.1152/physrev.00021.2006
Watanabe, 2008, TRP channel and cardiovascular disease, Pharmacol Therap, 118, 337, 10.1016/j.pharmthera.2008.03.008
Iwata, 2003, A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel, J Cell Biol, 161, 957, 10.1083/jcb.200301101
Suzuki, 2011, Adult onset cardiac dilatation in a transgenic mouse line with Galβ1,3GalNAc α2,3-sialyltransferase II (ST3Gal-II) transgenes: a new model for dilated cardiomyopathy, Proc Japan Acad, SerB, 87, 550, 10.2183/pjab.87.550
Iwata, 2009, Dominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal models, Hum Mol Genet, 18, 824, 10.1093/hmg/ddn408
Iwata, 1996, Dystrophin-glycoprotein complex purified from hamster cardiac muscle. Comparison of the complexes from cardiac and skeletal muscles of hamster and rabbit, J Mol Cell Cardiol, 28, 2501, 10.1006/jmcc.1996.9999
Nakamura, 2008, Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure, Circ Res, 103, 891, 10.1161/CIRCRESAHA.108.175141
Hu, 2004, 2-aminoethoxydiphenyl borate is a common activator of TRPV1, TRPV2, and TRPV3, J Biol Chem, 279, 35741, 10.1074/jbc.M404164200
Lievremont, 2005, Mechanism of inhibition of TRPC cation channels by 2-aminoethoxydiphenylborane, Mol Pharmacol, 68, 758, 10.1124/mol.105.012856
Iwata, 2005, Protective effects of Ca2+ handling drugs against abnormal Ca2+ homeostasis and cell damage in myopathic skeletal muscle cells, Biochem Pharmacol, 70, 740, 10.1016/j.bcp.2005.05.034
Mihara, 2010, Involvement of TRPV2 activation in intestinal movement through nitric oxide production in mice, J Neurosci, 30, 16536, 10.1523/JNEUROSCI.4426-10.2010
Houser, 2012, Animal models of heart failure: a scientific statement from the American Heart Association, Circ Res, 111, 131, 10.1161/RES.0b013e3182582523
Anderson, 2009, CaMKII and a failing strategy for growth in heart, J Clin Invest, 119, 1082, 10.1172/JCI39262
Giordano, 2005, Oxygen, oxidative stress, hypoxia, and heart failure, J Clin Invest, 115, 500, 10.1172/JCI200524408
Wilkins, 2004, Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy, Circ Res, 94, 110, 10.1161/01.RES.0000109415.17511.18
Molkentin, 1998, A calcineurin-dependent transcriptional pathway for cardiac hypertrophy, Cell, 93, 215, 10.1016/S0092-8674(00)81573-1
Wilkins, 2004, Calcium-calcineurin signaling in the regulation of cardiac hypertrophy, Biochem Biophys Res Commun, 322, 1178, 10.1016/j.bbrc.2004.07.121
Hwang, 2002, Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure, Physiol Genom, 10, 31, 10.1152/physiolgenomics.00122.2001
Toyo-Oka, 2004, Translocation and cleavage of myocardial dystrophin as a common pathway to advanced heart failure: a scheme for the progression of cardiac dysfunction, Proc Natl Acad Sci USA, 101, 7381, 10.1073/pnas.0401944101
Kanzaki, 1999, Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I, Nat Cell Biol, 1, 165, 10.1038/11086
Ruwhof, 2000, Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways, Cardiovasc Res, 47, 23, 10.1016/S0008-6363(00)00076-6
O'Quinn, 2011, A peptide mimetic of the connexin43 carboxyl terminus reduces gap junction remodeling and induced arrhythmia following ventricular injury, Circ Res, 108, 704, 10.1161/CIRCRESAHA.110.235747
Pae, 2008, Tranilast, an orally active anti-allergic drug, up-regulates the anti-inflammatory heme oxygenase-1 expression but down-regulates the pro-inflammatory cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW264.7 macrophages, Biochem Biophys Res Commun, 371, 361, 10.1016/j.bbrc.2008.04.054
Kelly, 2007, Tranilast attenuates diastolic dysfunction and structural injury in experimental diabetic cardiomyopathy, Am J Physiol Heart Circ Physiol, 293, H2860, 10.1152/ajpheart.01167.2006
Hara, 2002, Evidence for a role of mast cells in the evolution to congestive heart failure, J Exp Med, 195, 375, 10.1084/jem.20002036